Tolerability and Immunogenicity Study of FLUVAL P Monovalent Influenza Vaccine in Adults and Elderly Persons.

Trial Profile

Tolerability and Immunogenicity Study of FLUVAL P Monovalent Influenza Vaccine in Adults and Elderly Persons.

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Oct 2011

At a glance

  • Drugs Influenza A virus vaccine-H1N1; Influenza virus vaccine
  • Indications Influenza A virus H1N1 subtype; Influenza A virus infections; Influenza B virus infections
  • Focus Adverse reactions; Pharmacodynamics; Registrational
  • Most Recent Events

    • 19 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Oct 2011 Actual end date (February 2010) added as reported by ClinicalTrials.gov.
    • 16 Dec 2009 Results were published in the Lancet.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top